Cryo-EM structure of the human adenosine A1 receptor (A1R, white) in complex with the orthosteric agonist adenosine (magenta) ...

VRTX slips 9% in three months on slow new drug uptake and pipeline hiccups, but CF strength and 2025 growth offer a reason to ...

Patients with occipital headache experienced relief with 60 days of peripheral nerve stimulation, according to data presented ...

A sutureless device for peripheral nerve repair by medical technology company Tissium, which has its US office in Cambridge, ...

Moreover, SciatiEase Reviews frequently highlight inconsistent results: some customers report modest improvements in Sciatic ...

A burning sensation in the feet is usually harmless and temporary; however if it is chronic it can be due to various ...

The success of Vertex's opioid alternative Journavx could aid a group of biotechs that aim to take a similar path with NaV1.8 ...

Tissium announced today that it received FDA de novo marketing authorization for Coaptium Connect with Tissium Light.

The FDA cleared an artificial intelligence (AI)-powered wristband (Felix NeuroAI) to treat upper-limb functional limitations ...

An Omaha metro surgeon argues that tariffs on foreign-made pharmaceuticals would be catastrophic for his patients.

The Global Neuropathic Pain Market is valued approximately at USD 8.14 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.73% over the forecast period 2024-2032.

Type 2 diabetes is a long-term condition where the body can’t use insulin properly, causing blood sugar levels to stay too ...